论文部分内容阅读
浙江京新药业股份有限公司是一家集研发、生产、销售于一体的医药上市公司(股票代码:002020),国家重点高新技术企业,中国制药百强企业。公司总部设在浙江新昌,拥有五个生产基地,并在杭州和上海分别建有营销中心和药物研究中心。公司秉承“京新药,精心造”质量理念,已全面通过新版GMP认证,2006年率先通过了欧盟cGMP认证。公司主导产品包括化学药、特色中药和生物制剂三大类。
Zhejiang Jingxin Pharmaceutical Co., Ltd. is a listed pharmaceutical company (stock code: 002020), a national key high-tech enterprise and a top 100 Chinese pharmaceutical company, which integrates research and development, production and sales. The company is headquartered in Xinchang, Zhejiang, has five production bases, and in Hangzhou and Shanghai, respectively, built a marketing center and drug research center. Companies adhering to the “Beijing new drug, meticulously made ” quality philosophy, has been fully adopted the new GMP certification, in 2006 passed the EU cGMP certification. Company leading products, including chemical drugs, traditional Chinese medicine and biological agents three categories.